We are live on ! Find out more
EAM

Exane Asset Management Portfolio holdings

AUM $277M
1-Year Est. Return 26.27%
This Fund
S&P 500
This Quarter Est. Return
+8.16%
1 Year Est. Return
+26.27%
3 Year Est. Return
+77.5%
5 Year Est. Return
+80.92%
10 Year Est. Return
+419.8%
AUM
$512M
AUM Growth
+$191M
Cap. Flow
+$161M
Cap. Flow %
31.51%
Top 10 Hldgs %
57.05%
Holding
170
New
64
Increased
33
Reduced
12
Closed
56

Sector Composition

1 Healthcare 35.07%
2 Materials 23.96%
3 Communication Services 22.18%
4 Industrials 8.02%
5 Financials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
1
Gilead Sciences
GILD
$168B
$45.3M 8.86%
559,587
+225,985
+68% +$17.3M
QGEN icon
2
Qiagen
QGEN
$8.46B
$37.4M 7.3%
1,119,660
+517,172
+86% +$17.8M
T icon
3
AT&T
T
$151B
$32.3M 6.32%
1,093,207
+1,089,955
+33,516% +$30.9M
BMY icon
4
Bristol-Myers Squibb
BMY
$124B
$30.2M 5.9%
473,761
-80,601
-15% -$4.71M
VZ icon
5
Verizon
VZ
$181B
$27.5M 5.38%
555,860
+551,701
+13,265% +$26M
ASH icon
6
Ashland
ASH
$3.13B
$24.7M 4.83%
378,178
+101,463
+37% +$6.47M
CNH
7
CNH Industrial
CNH
$13.2B
$23.9M 4.67%
+2,285,324
New +$23M
APD icon
8
Air Products & Chemicals
APD
$66B
$23.6M 4.61%
155,811
+3,182
+2% +$466K
ECVT icon
9
Ecovyst
ECVT
$1.42B
$23.5M 4.6%
+1,363,925
New +$23.5M
BIIB icon
10
Biogen
BIIB
$30.2B
$23.5M 4.59%
74,948
+8,826
+13% +$2.61M
LBTYA icon
11
Liberty Global Class A
LBTYA
$3.52B
$21.8M 4.26%
643,336
+586,350
+1,029% +$19.5M
TIMB icon
12
TIM SA
TIMB
$10.5B
$21.4M 4.18%
1,169,592
-116,744
-9% -$2.03M
CF icon
13
CF Industries
CF
$18.7B
$15.3M 2.99%
+435,541
New +$13.4M
OLN icon
14
Olin
OLN
$2.5B
$15M 2.92%
436,579
+186,526
+75% +$5.81M
UNVR
15
DELISTED
Univar Solutions Inc.
UNVR
$14.4M 2.81%
+497,656
New +$14.3M
BAC icon
16
Bank of America
BAC
$430B
$12.7M 2.48%
500,000
ALXN
17
DELISTED
Alexion Pharmaceuticals
ALXN
$11.2M 2.19%
79,865
-12,908
-14% -$1.75M
BMRN icon
18
BioMarin Pharmaceuticals
BMRN
$11.5B
$11.2M 2.19%
+120,200
New +$10.6M
MRK icon
19
Merck
MRK
$314B
$10M 1.96%
+164,398
New +$9.97M
C icon
20
Citigroup
C
$218B
$9.09M 1.78%
125,000
DBVT
21
DBV Technologies
DBVT
$875M
$6.07M 1.19%
14,300
PCAR icon
22
PACCAR
PCAR
$66.5B
$5.12M 1%
106,248
-2,192
-2% -$98.9K
NXPI icon
23
NXP Semiconductors
NXPI
$67.5B
$4.62M 0.9%
40,840
+19,440
+91% +$2.17M
TWX
24
DELISTED
Time Warner Inc
TWX
$4.5M 0.88%
+43,900
New +$4.45M
MON
25
DELISTED
Monsanto Co
MON
$4.01M 0.78%
33,500
-166,010
-83% -$19.5M

Similar funds

Exane Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, Exane Asset Management held 170 positions worth $512M, up 60% from $321M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Exane Asset Management deployed $161M of net new capital in Q3 2017, opening 64 new positions and adding to 33 existing holdings. Its largest new stake was Ecovyst: 1,363,925 shares worth $23.5M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Materials and Communication Services.

On the sell side, the largest reduction was Monsanto Co, an estimated $19.5M trimmed.

  • Exane Asset Management's largest Q3 2017 buy was Ecovyst: 1,363,925 shares worth $23.5M.
  • Exane Asset Management added most to AT&T in Q3 2017, an estimated $30.9M increase.
  • Exane Asset Management's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $19.5M.
  • Exane Asset Management fully exited Celgene Corp in Q3 2017, selling an estimated $13.2M.
  • Exane Asset Management's ten largest holdings make up 57% of its $512M portfolio in Q3 2017.
  • Exane Asset Management opened 64 new positions and closed 56 in Q3 2017.
  • Exane Asset Management's portfolio value rose 60% quarter-over-quarter to $512M.

Based on Exane Asset Management's 13F filing for Q3 2017, filed 13 Oct 2017.